Declared Dividend • Aug 04
First quarter dividend increased to US$0.20 Dividend of US$0.20 is 5.3% higher than last year. Ex-date: 14th August 2026 Payment date: 28th August 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 20%. Cash payout ratio: 17%. Reported Earnings • Jul 30
First quarter 2027 earnings: EPS misses analyst expectations First quarter 2027 results: EPS: US$1.36 (down from US$1.41 in 1Q 2026). Revenue: US$315.7m (up 7.6% from 1Q 2026). Net income: US$28.3m (down 3.2% from 1Q 2026). Profit margin: 9.0% (in line with 1Q 2026). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.2%. Revenue is forecast to grow 6.0% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Live-nyheter • Jul 30
Hawkins Reports Record Revenue and Completes Aqua-Chem Acquisition in First Quarter Hawkins reported record first quarter fiscal 2027 revenue of $315.7m, with management citing contributions from Water Treatment, Food & Health Sciences and Industrial Solutions. The company also closed the acquisition of Aqua-Chem, Inc., which is intended to support its Water Treatment growth strategy.
The company highlighted ongoing efforts to reduce debt and direct capital toward higher-margin businesses, while also pointing to recent stabilization in previously volatile raw material costs.
Hawkins shares trade at $138.60, with the stock down 17.2% over the past 90 days.
The combination of record quarterly revenue and the Aqua-Chem acquisition indicates Hawkins is increasing its focus on Water Treatment and higher-margin areas while still prioritizing balance sheet strength. The recent share price pullback in this context may draw attention to how the Aqua-Chem integration and the cost environment influence profitability and cash generation. Tillkännagivande • Jul 30
Hawkins, Inc. Increases Quarterly Cash Dividend, Payable August 28, 2026 The Board of Directors of Hawkins, Inc., at its meeting on July 29, 2026, increased its quarterly cash dividend by 5% to $0.20 per share, payable August 28, 2026, to shareholders of record at the close of business on August 14, 2026. Tillkännagivande • Jul 15
Hawkins, Inc. to Report Q1, 2027 Results on Jul 29, 2026 Hawkins, Inc. announced that they will report Q1, 2027 results at 4:10 PM, US Eastern Standard Time on Jul 29, 2026 Valuation Update With 7 Day Price Move • Jul 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to US$138, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 17x in the Chemicals industry in the US. Total returns to shareholders of 201% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$145 per share. Tillkännagivande • Jun 20
Hawkins, Inc., Annual General Meeting, Jul 29, 2026 Hawkins, Inc., Annual General Meeting, Jul 29, 2026. Declared Dividend • May 20
Fourth quarter dividend of US$0.19 announced Shareholders will receive a dividend of US$0.19. Ex-date: 29th May 2026 Payment date: 12th June 2026 Dividend yield will be 0.5%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 19%. Cash payout ratio: 18%. Reported Earnings • May 14
Full year 2026 earnings: Revenues and EPS in line with analyst expectations Full year 2026 results: EPS: US$3.93 (down from US$4.05 in FY 2025). Revenue: US$1.08b (up 11% from FY 2025). Net income: US$81.5m (down 3.3% from FY 2025). Profit margin: 7.5% (down from 8.7% in FY 2025). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 5.1% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • May 14
Hawkins, Inc. Declares Quarterly Cash Dividend, Payable on June 12, 2026 The Board of Directors of Hawkins, Inc. at its meeting on May 13, 2026, declared a quarterly cash dividend of $0.19 per share, payable June 12, 2026, to shareholders of record at the close of business on May 29, 2026. Live-nyheter • May 14
Hawkins Reports Record Sales With Water Treatment Growth and Eyes Lower Leverage for 2027 Hawkins reported record fourth quarter sales for fiscal 2026, with performance supported by 16% growth in its Water Treatment segment.
The company completed six acquisitions during fiscal 2026, largely focused on expanding its Water Treatment operations.
Management signaled expectations for revenue and operating income growth across all segments in fiscal 2027 and is targeting a leverage ratio of about 1x adjusted EBITDA by year-end.
The focus on Water Treatment, both through organic growth and acquisitions, points to this segment becoming an increasingly important driver within Hawkins’ overall business mix.
For you as an investor, the plan to reduce leverage to around 1x adjusted EBITDA may be worth tracking, since it speaks to how much balance sheet flexibility the company could have for future investments or downturns. Tillkännagivande • Apr 29
Hawkins, Inc. to Report Q4, 2026 Results on May 13, 2026 Hawkins, Inc. announced that they will report Q4, 2026 results at 4:10 PM, US Eastern Standard Time on May 13, 2026 Buy Or Sell Opportunity • Mar 23
Now 22% overvalued Over the last 90 days, the stock has fallen 4.4% to US$141. The fair value is estimated to be US$115, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 18% in the next 2 years. Recent Insider Transactions • Feb 08
Independent Director recently bought US$389k worth of stock On the 5th of February, James Faulconbridge bought around 3k shares on-market at roughly US$130 per share. This transaction amounted to 6.1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$589k more in shares than they have sold in the last 12 months. Buy Or Sell Opportunity • Feb 06
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 5.1% to US$134. The fair value is estimated to be US$112, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 12% in 2 years. Earnings are forecast to grow by 18% in the next 2 years. Valuation Update With 7 Day Price Move • Feb 04
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to US$129, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 17x in the Chemicals industry in the US. Total returns to shareholders of 222% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$108 per share. Recent Insider Transactions Derivative • Feb 03
Executive Officer notifies of intention to sell stock Richard Erstad intends to sell 4k shares in the next 90 days after lodging an Intent To Sell Form on the 2nd of February. If the sale is conducted around the recent share price of US$130, it would amount to US$454k. Since March 2025, Richard's direct individual holding has increased from 62.75k shares to 67.23k. There has only been one transaction (US$201k purchase) from insiders over the last 12 months. Tillkännagivande • Feb 03
Hawkins, Inc. Announces Milestone for Its Watersurplus Nanostack™? Membranes Hawkins, Inc. announced the successful completion of a multi-year pilot test featuring WaterSurplus' patented NanoStack coated membranes at the Orange County Water District's (OCWD) Groundwater Replenishment System (GWRS). WaterSurplus is a wholly owned subsidiary of Hawkins, Inc. and is located in Loves Park, IL. Based on the successful pilot, OCWD will install 1,050 NanoStack coated membranes at GWRS, the world's advanced water purification system for potable water reuse. This quantity represents one full reverse osmosis train, treating approximately 5 million gallons of water per day for indirect potable reuse. Pilot testing data demonstrated that NanoStack technology significantly improved fouling resistance, cutting clean-in-place requirements by more than half, and reducing RO energy consumption by more than 15%. Given that energy is one of the largest operating costs for advanced water treatment facilities, these savings are estimated to enable a payment period of less than two years, according to WaterSurplus' Chief Technology Officer, Dr. Dileep Aggnihotri. NanoStack is an NSF/ANSI/CAN 61-certified hydrophilic membrane surface modification that is applied to finished RO membrane elements. This advanced coating enhances membrane durability and performance, helping customers across industries achieve more reliable long-term operation with lower lifecycle costs. Declared Dividend • Feb 01
Third quarter dividend of US$0.19 announced Shareholders will receive a dividend of US$0.19. Ex-date: 13th February 2026 Payment date: 27th February 2026 Dividend yield will be 0.6%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 19%. Cash payout ratio: 18%. Reported Earnings • Jan 29
Third quarter 2026 earnings: EPS and revenues miss analyst expectations Third quarter 2026 results: EPS: US$0.69 (down from US$0.72 in 3Q 2025). Revenue: US$244.1m (up 7.9% from 3Q 2025). Net income: US$14.3m (down 4.7% from 3Q 2025). Profit margin: 5.9% (down from 6.6% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.3%. Earnings per share (EPS) also missed analyst estimates by 7.3%. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jan 29
Hawkins, Inc. Declares Quarterly Cash Dividend, Payable on February 27, 2026 At its recent board meeting, the Board of Directors of Hawkins, Inc. declared a quarterly cash dividend of $0.19 per share, payable February 27, 2026, to shareholders of record at the close of business on February 13, 2026. Tillkännagivande • Jan 14
Hawkins, Inc. to Report Q3, 2026 Results on Jan 28, 2026 Hawkins, Inc. announced that they will report Q3, 2026 results at 4:10 PM, US Eastern Standard Time on Jan 28, 2026 Tillkännagivande • Dec 19
Hawkins, Inc. Announces Retirement of Richard G. Erstad as General Counsel and Secretary, Effective December 28, 2025 Hawkins, Inc. announced that Richard G. Erstad, Vice President, General Counsel, and Secretary, informed the company of his intention to retire, having served in these roles at the company for 17 years. As one of the initial steps of a planned transition, Mr. Erstad is expected to cease to serve as an executive officer of the company effective December 28, 2025, the end of the third fiscal quarter. To ensure a smooth transition, he is expected to remain engaged as an employee of the company until May 2026. Valuation Update With 7 Day Price Move • Nov 05
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to US$127, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 14x in the Chemicals industry in the US. Total returns to shareholders of 218% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$99.30 per share. Declared Dividend • Nov 02
Second quarter dividend of US$0.19 announced Shareholders will receive a dividend of US$0.19. Ex-date: 14th November 2025 Payment date: 28th November 2025 Dividend yield will be 0.5%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 18%. Cash payout ratio: 20%. Reported Earnings • Oct 30
Second quarter 2026 earnings: EPS and revenues miss analyst expectations Second quarter 2026 results: EPS: US$1.09 (down from US$1.16 in 2Q 2025). Revenue: US$280.4m (up 14% from 2Q 2025). Net income: US$22.6m (down 6.3% from 2Q 2025). Profit margin: 8.1% (down from 9.8% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Oct 30
Hawkins, Inc. Declares Quarterly Cash Dividend, Payable on November 28, 2025 At its recent board meeting, the Board of Directors of Hawkins, Inc. declared a quarterly cash dividend of $0.19 per share, payable November 28, 2025, to shareholders of record at the close of business on November 14, 2025. Tillkännagivande • Oct 15
Hawkins, Inc. to Report Q2, 2026 Results on Oct 29, 2025 Hawkins, Inc. announced that they will report Q2, 2026 results at 4:10 PM, US Eastern Standard Time on Oct 29, 2025 Price Target Changed • Sep 16
Price target increased by 12% to US$166 Up from US$148, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of US$173. Stock is up 44% over the past year. The company is forecast to post earnings per share of US$4.37 for next year compared to US$4.05 last year. Buy Or Sell Opportunity • Aug 08
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 48% to US$177. The fair value is estimated to be US$147, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.4% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 16% in 2 years. Earnings are forecast to grow by 22% in the next 2 years. Price Target Changed • Aug 04
Price target increased by 10% to US$164 Up from US$148, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$169. Stock is up 47% over the past year. The company is forecast to post earnings per share of US$4.34 for next year compared to US$4.05 last year. Declared Dividend • Aug 03
First quarter dividend increased to US$0.19 Dividend of US$0.19 is 5.6% higher than last year. Ex-date: 15th August 2025 Payment date: 29th August 2025 Dividend yield will be 0.5%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 18%. Cash payout ratio: 19%. Reported Earnings • Jul 31
First quarter 2026 earnings: EPS and revenues exceed analyst expectations First quarter 2026 results: EPS: US$1.41 (up from US$1.39 in 1Q 2025). Revenue: US$293.3m (up 15% from 1Q 2025). Net income: US$29.2m (up 1.0% from 1Q 2025). Profit margin: 9.9% (down from 11% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 5.2%. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 61% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jul 31
Hawkins, Inc. Declares Quarterly Cash Dividend, Payable on August 29, 2025 The Board of Directors of Hawkins, Inc. at its meeting on July 30, 2025, increased its quarterly cash dividend by 6% to $0.19 per share, payable August 29, 2025, to shareholders of record at the close of business on August 15, 2025. Tillkännagivande • Jul 16
Hawkins, Inc. to Report Q1, 2026 Results on Jul 30, 2025 Hawkins, Inc. announced that they will report Q1, 2026 results at 4:10 PM, US Eastern Standard Time on Jul 30, 2025 Buy Or Sell Opportunity • Jun 27
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 36% to US$144. The fair value is estimated to be US$120, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.4% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 15% in 2 years. Earnings are forecast to grow by 17% in the next 2 years. Tillkännagivande • Jun 19
Hawkins, Inc., Annual General Meeting, Jul 30, 2025 Hawkins, Inc., Annual General Meeting, Jul 30, 2025. Declared Dividend • May 18
Fourth quarter dividend of US$0.18 announced Shareholders will receive a dividend of US$0.18. Ex-date: 30th May 2025 Payment date: 13th June 2025 Dividend yield will be 0.6%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 17%. Cash payout ratio: 21%. Reported Earnings • May 15
Full year 2025 earnings: EPS in line with analyst expectations despite revenue beat Full year 2025 results: EPS: US$4.05 (up from US$3.61 in FY 2024). Revenue: US$974.4m (up 6.0% from FY 2024). Net income: US$84.3m (up 12% from FY 2024). Profit margin: 8.7% (up from 8.2% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 4.9% p.a. on average during the next 2 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • May 15
Hawkins, Inc. Declares Quarterly Cash Dividend, Payable on June 13, 2025 The Board of Directors of Hawkins, Inc. at its meeting on May 14, 2025, declared a quarterly cash dividend of $0.18 per share, payable June 13, 2025, to shareholders of record at the close of business on May 30, 2025. Tillkännagivande • Apr 30
Hawkins, Inc. to Report Q4, 2025 Results on May 14, 2025 Hawkins, Inc. announced that they will report Q4, 2025 results at 4:10 PM, US Eastern Standard Time on May 14, 2025 Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to US$124, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 14x in the Chemicals industry in the US. Total returns to shareholders of 210% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$99.79 per share. Buy Or Sell Opportunity • Apr 14
Now 24% overvalued after recent price rise Over the last 90 days, the stock has risen 11% to US$124. The fair value is estimated to be US$99.79, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 6.5% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 11% in 2 years. Earnings are forecast to grow by 15% in the next 2 years. Declared Dividend • Feb 02
Third quarter dividend of US$0.18 announced Shareholders will receive a dividend of US$0.18. Ex-date: 14th February 2025 Payment date: 28th February 2025 Dividend yield will be 0.7%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 17%. Cash payout ratio: 19%. Reported Earnings • Jan 30
Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2025 results: EPS: US$0.72 (up from US$0.72 in 3Q 2024). Revenue: US$226.2m (up 8.5% from 3Q 2024). Net income: US$15.0m (flat on 3Q 2024). Profit margin: 6.6% (down from 7.1% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.2%. Earnings per share (EPS) missed analyst estimates by 7.0%. Revenue is forecast to grow 6.3% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jan 30
Hawkins, Inc. Declares Quarterly Cash Dividend, Payable on February 28, 2025 The Board of Directors of Hawkins, Inc. at its meeting on January 29, 2025, declared a quarterly cash dividend of $0.18 per share, payable February 28, 2025, to shareholders of record at the close of business on February 14, 2025. Tillkännagivande • Jan 15
Hawkins, Inc. to Report Q3, 2025 Results on Jan 29, 2025 Hawkins, Inc. announced that they will report Q3, 2025 results at 4:10 PM, US Eastern Standard Time on Jan 29, 2025 Valuation Update With 7 Day Price Move • Nov 08
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to US$125, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 19x in the Chemicals industry in the US. Total returns to shareholders of 249% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$70.90 per share. Declared Dividend • Nov 03
Second quarter dividend of US$0.18 announced Shareholders will receive a dividend of US$0.18. Ex-date: 15th November 2024 Payment date: 29th November 2024 Dividend yield will be 0.6%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 17%. Cash payout ratio: 18%. Reported Earnings • Nov 01
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: EPS: US$1.16 (up from US$1.11 in 2Q 2024). Revenue: US$247.0m (up 4.4% from 2Q 2024). Net income: US$24.1m (up 3.9% from 2Q 2024). Profit margin: 9.8% (in line with 2Q 2024). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) also missed analyst estimates by 1.9%. Revenue is forecast to grow 8.5% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Oct 16
Hawkins, Inc. to Report Q2, 2025 Results on Oct 30, 2024 Hawkins, Inc. announced that they will report Q2, 2025 results at 4:10 PM, US Eastern Standard Time on Oct 30, 2024 Major Estimate Revision • Aug 07
Consensus EPS estimates increase by 13% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from US$3.67 to US$4.14. Revenue forecast steady at US$988.7m. Net income forecast to grow 8.6% next year vs 38% growth forecast for Chemicals industry in the US. Consensus price target up from US$96.50 to US$123. Share price rose 15% to US$119 over the past week. Declared Dividend • Aug 04
First quarter dividend increased to US$0.18 Dividend of US$0.18 is 13% higher than last year. Ex-date: 16th August 2024 Payment date: 30th August 2024 Dividend yield will be 0.5%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 17%. Cash payout ratio: 13%. Reported Earnings • Aug 01
First quarter 2025 earnings: EPS exceeds analyst expectations First quarter 2025 results: EPS: US$1.39 (up from US$1.12 in 1Q 2024). Revenue: US$255.9m (up 1.9% from 1Q 2024). Net income: US$28.9m (up 23% from 1Q 2024). Profit margin: 11% (up from 9.3% in 1Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 37%. Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Aug 01
Hawkins, Inc. Increases Its Quarterly Cash Dividend, Payable on August 30, 2024 The Board of Directors of Hawkins, Inc. at its meeting on July 31, 2024, increased its quarterly cash dividend by 13% to $0.18 per share, payable August 30, 2024, to shareholders of record at the close of business on August 16, 2024. Tillkännagivande • Jul 17
Hawkins, Inc. to Report Q1, 2025 Results on Jul 31, 2024 Hawkins, Inc. announced that they will report Q1, 2025 results at 4:10 PM, US Eastern Standard Time on Jul 31, 2024 Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to US$108, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 17x in the Chemicals industry in the US. Total returns to shareholders of 259% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$65.25 per share. Tillkännagivande • Jun 22
Hawkins, Inc., Annual General Meeting, Jul 31, 2024 Hawkins, Inc., Annual General Meeting, Jul 31, 2024. Recent Insider Transactions • Jun 13
Independent Director recently bought US$289k worth of stock On the 7th of June, James Faulconbridge bought around 3k shares on-market at roughly US$87.55 per share. This transaction amounted to 8.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$453k more in shares than they have sold in the last 12 months. Tillkännagivande • Jun 05
Hawkins, Inc. (NasdaqGS:HWKN) acquired Assets of Intercoastal Trading Inc. Hawkins, Inc. (NasdaqGS:HWKN) acquired Assets of Intercoastal Trading Inc. on June 3, 2024.Hawkins, Inc. (NasdaqGS:HWKN) completed the acquisition of Assets of Intercoastal Trading Inc. on June 3, 2024. Valuation Update With 7 Day Price Move • May 22
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to US$88.68, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 19x in the Chemicals industry in the US. Total returns to shareholders of 185% over the past three years. Declared Dividend • May 19
Fourth quarter dividend of US$0.16 announced Shareholders will receive a dividend of US$0.16. Ex-date: 31st May 2024 Payment date: 14th June 2024 Dividend yield will be 0.8%, which is lower than the industry average of 2.0%. Payout Ratios Payout ratio: 17%. Cash payout ratio: 11%. Reported Earnings • May 16
Full year 2024 earnings: Revenues and EPS in line with analyst expectations Full year 2024 results: EPS: US$3.61 (up from US$2.88 in FY 2023). Revenue: US$919.2m (down 1.7% from FY 2023). Net income: US$75.4m (up 26% from FY 2023). Profit margin: 8.2% (up from 6.4% in FY 2023). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • May 16
Hawkins, Inc. Declares Quarterly Cash Dividend, Payable June 14, 2024 The Board of Directors of Hawkins, Inc., at its meeting on May 15, 2024, declared a quarterly cash dividend of $0.16 per share payable June 14, 2024, to shareholders of record at the close of business on May 31, 2024. Tillkännagivande • May 03
Hawkins, Inc. to Report Q4, 2024 Results on May 15, 2024 Hawkins, Inc. announced that they will report Q4, 2024 results at 4:10 PM, US Eastern Standard Time on May 15, 2024 Upcoming Dividend • Feb 08
Upcoming dividend of US$0.16 per share at 1.0% yield Eligible shareholders must have bought the stock before 15 February 2024. Payment date: 01 March 2024. Payout ratio is a comfortable 18% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of American dividend payers (4.8%). Lower than average of industry peers (2.1%). Declared Dividend • Feb 04
Third quarter dividend of US$0.16 announced Shareholders will receive a dividend of US$0.16. Ex-date: 15th February 2024 Payment date: 1st March 2024 Dividend yield will be 1.0%, which is lower than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (18% earnings payout ratio) and cash flows (13% cash payout ratio). The dividend has increased by an average of 5.9% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 2.8% over the next year, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Feb 01
Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2024 results: EPS: US$0.72 (up from US$0.52 in 3Q 2023). Revenue: US$208.5m (down 4.9% from 3Q 2023). Net income: US$14.9m (up 39% from 3Q 2023). Profit margin: 7.1% (up from 4.9% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) exceeded analyst estimates by 16%. Revenue is forecast to grow 5.8% p.a. on average during the next 2 years, compared to a 4.3% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. 
